C4orf46
Renal cancer differentiation gene 1 protein
Also known as: CD046_HUMAN, LOC201725, RCDG1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q504U0
- Gene
- C4orf46
- Ensembl
- ENSG00000205208
- Chromosome
- 4
- Canonical length
- 113 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Cytosol
OverviewNCBI Gene
This gene encodes a small, conserved protein of unknown function that is expressed in a variety of tissues. There are pseudogenes for this gene on chromosomes 6, 8, 16, and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2013]
Canonical amino-acid sequenceUniProt
113 residues, UniProt reviewed canonical sequence.
>Q504U0|C4orf46
1 MADPEELQVS SPPPPPPSSP SSSDASAASS PGGPVSLGWP VPSRSSGPTV DQLEEVELQI
61 GDAAFSLTKL LEATSAVSAQ VEELAFKCTE NARFLKTWRD LLKEGYDSLK PDDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against C4orf46 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.6
- Highest tissue expression
- 14 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 14 nTPM
- testis: 12 nTPM
- thymus: 9.5 nTPM
- retina: 8.7 nTPM
- lymph node: 5.6 nTPM
- tongue: 5.6 nTPM
Single-cell type
- late primary spermatocytes: 60 nCPM
- early primary spermatocytes: 44 nCPM
- rod photoreceptor cells: 34 nCPM
- melanocytes: 31 nCPM
- monocyte progenitors: 29 nCPM
- endometrial luminal cells: 24 nCPM
Immune cell
- NK-cell: 3.4 nTPM
- basophil: 2.4 nTPM
- naive CD8 T-cell: 2.3 nTPM
- non-classical monocyte: 2.2 nTPM
- myeloid DC: 2.1 nTPM
- naive CD4 T-cell: 2.1 nTPM
Brain region
- white matter: 4.9 nTPM
- cerebellum: 3.9 nTPM
- basal ganglia: 3.8 nTPM
- medulla oblongata: 3.7 nTPM
- midbrain: 3.5 nTPM
- cerebral cortex: 3.3 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.76
- gnomAD pLI
- 0.04
- gnomAD missense Z
- -0.24
- DepMap mean gene effect
- -0.08
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Renal cancer differentiation gene 1 protein
- Renal cancer differentiation gene 1 protein
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of C4orf46 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads C4orf46 as an antibody target. Whether an autoantibody or antibody against C4orf46 could matter depends on whether native C4orf46 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
C4orf46 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label C4orf46 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...